Post-treatment expression of inflammatory cytokines in cecum contents showed that cisplatin treatment-induced IL-6, IL-1β, MCP, and IFN-γ significantly increased compared with NSCLC group, and the situation was reversed by BFHY (Figure 2(b)). Here, IL1B is linked to non-small cell lung carcinoma.